Alzheimer's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 18 years of age or older
- People who identify as Latino and speak Spanish or English
- People who provide hands-on care for a family member who has been diagnosed with Alzheimer's disease or a related dementia condition, and whose family member scores 2 or higher on a standard cognitive screening tool (confirm with trial site)
- People whose own responses to a standard depression questionnaire score 7 or higher out of 10 (confirm with trial site)
- People who are able to read and write
- People who own a cell phone with a flat-rate plan and use it for texting at least once a week
Who may not be able to join:
- People who are currently taking part in another clinical trial focused on wellbeing
- People who live in the same household as another participant already enrolled in this specific study (called the CuidaTEXT R01 Study)
- People who are caring for the same person with dementia as another participant already enrolled in this study
- People who are planning to move to another country within the next seven months
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jaime Perales Puchalt, PhD, MPH, University of Kansas Medical Center
Phone: 913-945-5052
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in caregiver depressive symptoms
Can't join this trial?
Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.